You just read:

Effect of PectaSol-C® modified citrus pectin (P-MCP) treatment (tx) on PSA dynamics in patients (pts) with nonmetastatic, biochemically relapsed prostate cancer (BRPC): Results of the interim analysis of a prospective phase II study

News provided by

Better Health Publishing

Jun 19, 2017, 13:03 ET